Best Compounded Tirzepatide Providers 2026

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you’re searching for the best compounded tirzepatide provider in 2026, the rankings you’ll see across affiliate-driven roundups generally cycle through the same five names: MEDVi, Eden, Yucca Health, Willow, and Trim RX. Each has a specific angle — MEDVi pitches all-inclusive support and a money-back policy, Eden runs flat-rate dose pricing, Yucca undercuts on first-month cost, Willow optimizes for same-day prescriptions, and Trim RX bundles supplements. None of them include a genetic baseline before titration. This article walks through how those five compare, names the medication-source and clinical-oversight variables that actually matter, and shows where PlexusDx Tirzepatide Injection Protocol ($249/mo) and Tirzepatide Oral Protocol ($279/mo) sit relative to that field — because the right provider isn’t the one with the loudest ad budget. It’s the one whose pricing, oversight, and personalization match how you actually plan to use a GLP-1.

The 2026 compounded tirzepatide landscape — who’s being compared

The provider field in this category narrowed substantially after the FDA shortage list closed for tirzepatide. The five providers cited most often in 2026 roundups — MEDVi, Eden, Yucca Health, Willow, and Trim RX — all source from licensed U.S. compounding pharmacies (503A facilities, occasionally with 503B partners) and operate as cash-pay telehealth programs. Pricing on the affiliate page lands roughly like this: MEDVi at $349/mo for tirzepatide injections and $279/mo for tablets, Eden at a flat $349/mo across every dose, Yucca Health at $258 for the first month on a 6-month plan and $325/mo thereafter, Willow starting at $399/mo, and Trim RX at $235/mo. PlexusDx is not on most affiliate roundups because we don’t pay for placement — but our protocol pricing is materially more competitive at the entry tier. Tirzepatide Injection Protocol runs $249/mo across six dose levels (2.5mg to 15mg weekly), and the Tirzepatide Oral Protocol runs $279/mo across seven daily dose levels (5mg to 25mg). Both are all-inclusive: clinical consultation, prescription, compounded medication, and shipping in one bill, with no membership fee.

How the five most-ranked providers actually compare

Strip the “best for X” affiliate copy and the providers cluster around a few real differentiators. MEDVi emphasizes 24/7 clinician access, both injectable and oral tirzepatide, and a money-back guarantee — its Trustpilot footprint is the largest of the five (8,100+ reviews, 4.4/5). Eden stands out for flat-rate $349/mo pricing that doesn’t escalate with dose — useful for patients who expect to titrate to higher weekly doses. Yucca Health wins on absolute first-month price ($258 on a 6-month plan) but locks you into the multi-month commitment to get there. Willow optimizes for time-to-first-injection — same-day consult, free 2-day shipping — at the cost of a higher entry price. Trim RX advertises the lowest sticker ($235/mo) and a 90-day results guarantee with bundled supplements. None of them include a genetic test before dose selection. None of them offer a daily oral tirzepatide formulation at the price point PlexusDx does. And none separate the cost of compounded medication from the cost of clinical oversight — for better or worse, it’s one bundled monthly bill.

Where PlexusDx sits in the field

PlexusDx wasn’t built to compete on the affiliate-driven “cheapest first month” axis. We were built to be the GLP-1 protocol that incorporates a genetic baseline, offers more delivery formats than any of the five providers above, and prices below the field at the entry dose tier. The Tirzepatide Injection Protocol at $229/mo entry is below MEDVi ($349), Eden ($349), Yucca ($325 maintenance), Willow ($399), and matches Trim RX ($235) while including a clinical pathway through licensed U.S. compounding pharmacies and an optional Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month). The Tirzepatide Oral Protocol at $229/mo entry is the most accessibly priced compounded oral tirzepatide option in the comparison — useful if you’ve had trouble with weekly injection routines, need a needle-free option, or want a daily dosing rhythm. For patients who want full GIP/GLP-1 dual-agonist mechanism with semaglutide stacking, GLP-Squared ($249/mo) is the dual-compound path none of the five providers offer.

Compounded vs FDA-approved tirzepatide — what each provider actually dispenses

This is the substantive medication question and it applies equally to all six providers in the comparison (the five from the affiliate roundup plus PlexusDx). Compounded tirzepatide is prepared by a licensed compounding pharmacy under U.S. compounding regulations — Section 503A for state-licensed pharmacies that prepare individual prescriptions, or Section 503B for FDA-registered outsourcing facilities operating under cGMP standards. Compounded tirzepatide contains the same tirzepatide active ingredient as Mounjaro and Zepbound, but the finished product has not been FDA-approved — it’s legal under the compounding statute, not under the new-drug-approval pathway. Mounjaro and Zepbound are the only FDA-approved finished tirzepatide products. The boxed warning for thyroid C-cell tumors applies to tirzepatide as a class based on rodent studies, regardless of whether the formulation is compounded or branded. None of the five providers in the source roundup — and PlexusDx is no different — can lawfully advertise compounded tirzepatide as “FDA-approved.” Any provider that does should be removed from your shortlist.

Why genetics matter before dose selection

Tirzepatide’s dual GIP/GLP-1 mechanism produces meaningful weight loss in clinical trials — SURMOUNT-1 reported an average 20.9% body-weight reduction over 72 weeks at the 15mg dose. But the response distribution is wide. Variants in GIPR (the GIP receptor itself, including rs1800437), GLP1R (the GLP-1 receptor), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with different response patterns to tirzepatide and semaglutide. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights, with the GIPR rs1800437 variant flagged for differential GLP-1/GIP response. None of MEDVi, Eden, Yucca Health, Willow, or Trim RX includes a genetic baseline as part of titration. PlexusDx is the only protocol in the comparison that anchors dose decisions to a measurable genetic signal — available standalone for $298 or as a $99 add-on after your first month on any protocol.

Real annualized cost — PlexusDx vs the affiliate field

Provider rankings tend to feature the “starting at” price, not what you’ll actually pay across a year of titration. Annualized totals for a maintenance plan landing in the middle of the dose range look like this: MEDVi runs roughly $4,188–$5,988/year on tirzepatide injections at $349–$499/mo; Eden runs $4,188/year flat at $349/mo; Yucca Health runs roughly $3,883/year on the 6-month plan ($258 + $325 × 11); Willow runs $4,788+ at $399/mo; Trim RX runs $2,820/year at $235/mo flat. PlexusDx Tirzepatide Injection Protocol runs $2,748–$3,708/year across the $249/mo range, and Tirzepatide Oral Protocol runs $2,748–$6,108/year across the $279/mo range. At the entry tier ($229/mo), PlexusDx is the lowest-priced of the seven-way comparison. Adding the $99 Precision Peptide Genetic Test after month one keeps the genetic-baseline-included total below MEDVi, Eden, Yucca’s maintenance, and Willow on the injection path. The arithmetic only flips at the highest oral dose tiers, where dose escalation drives the per-month price up.

How to choose the right compounded tirzepatide provider

The decision frame depends on what you’re optimizing for. If you want the lowest sticker price and don’t need a genetic baseline, Trim RX at $235/mo flat or PlexusDx Tirzepatide Injection at $229/mo entry are the closest in cost. If you need an oral tirzepatide formulation rather than an injection, PlexusDx Tirzepatide Oral Protocol ($279/mo) and MEDVi’s tirzepatide tablets ($279/mo) are the two named programs in the comparison. If you want flat-rate pricing that doesn’t scale with dose, Eden at $349/mo flat is the cleanest. If you want a money-back guarantee, MEDVi or Trim RX are the two with publicly posted refund policies. If you want a genetic baseline before titration, PlexusDx is the only provider in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway. If you want a stacked semaglutide + tirzepatide path, GLP-Squared is the only dual-compound option named here.

Frequently asked questions

Is compounded tirzepatide the same as Mounjaro or Zepbound?

Compounded tirzepatide contains the same tirzepatide active ingredient as Mounjaro and Zepbound, but the finished product is prepared by a licensed compounding pharmacy and has not been FDA-approved as a finished drug. Compounded formulations are legal under Section 503A or 503B of the federal compounding statute when prescribed for an individual patient. The PlexusDx Tirzepatide Injection Protocol ($249/mo) and Tirzepatide Oral Protocol ($279/mo) use compounded tirzepatide from licensed U.S. compounding pharmacies.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide — from PlexusDx, MEDVi, Eden, Yucca Health, Willow, Trim RX, or any other provider — is not FDA-approved as a finished product. Mounjaro and Zepbound are the only FDA-approved finished tirzepatide products. Compounded preparations are legal under the federal compounding statute when prescribed by a licensed clinician for an individual patient.

What is the cheapest compounded tirzepatide provider?

On a per-month basis, PlexusDx Tirzepatide Injection at $229/mo entry is the lowest-priced option in this comparison. Trim RX is next at $235/mo flat. Yucca Health offers the lowest first-month price ($258 on a 6-month plan), but maintenance pricing rises to $325/mo. Cheapest sticker price is rarely the right decision frame — weigh medication source, clinical oversight, and whether a genetic baseline is included.

Is the PlexusDx Tirzepatide Oral Protocol the same as a tirzepatide tablet?

Yes — the Tirzepatide Oral Protocol is a daily oral compounded tirzepatide formulation, prepared by a licensed U.S. compounding pharmacy and dosed across seven levels from 5mg to 25mg daily. It runs $279/mo. Compared to MEDVi’s tirzepatide tablets at $279/mo entry, PlexusDx is priced more accessibly at the starting dose.

Can I switch from injection to oral tirzepatide on PlexusDx?

Yes, with your provider’s guidance. The active ingredient is tirzepatide in both delivery formats, so the clinician can manage the transition between the Tirzepatide Injection Protocol and the Tirzepatide Oral Protocol. Dose equivalencies differ between weekly injection and daily oral dosing — that’s a clinical conversation, not a self-titration decision.

Do PlexusDx protocols include a genetic test?

The Precision Peptide Genetic Test is optional — $298 standalone or $99 as an add-on after your first month on any PlexusDx protocol. It maps 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GIP/GLP-1 response. None of MEDVi, Eden, Yucca Health, Willow, or Trim RX includes a comparable genetic baseline.

What are the red flags of a fake or unsafe compounded tirzepatide provider?

Watch for: no prescription required; refusal to name the compounding pharmacy; marketing the product as “generic Mounjaro” or “FDA-approved” (compounded tirzepatide is neither); unusually low prices with no explanation; no clinician involvement; “research use only” labeling; and no third-party reviews on Trustpilot, ConsumerAffairs, or the BBB. Reputable cash-pay programs name their pharmacies, require a licensed clinician’s prescription, and post clear refund and shipping policies.

Best Compounded Tirzepatide Providers (2026): How PlexusDx Compares | PlexusDx